Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Ashe Insider Profile
11 Followers
Andrew Ashe, General Counsel & EVP at Dyax Corp, holds 0.00 shares in Dyax Corp (Ticker: DYAX), holds ― shares in Applied Genetic Technologies (Ticker: AGTC), holds 342.51K shares in Verve Therapeutics (Ticker: VERV).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-29.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
President, COO
Roles that Andrew Ashe holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Ashe
Andrew Ashe's Trading History
Dyax Corp
Jan 22, 2016
―
Uninformative Sell
―
$0.00
Applied Genetic Technologies
―
―
―
―
Verve Therapeutics
May 15, 2024
President, COO
Informative Buy
475.76K
$1.97M
List of latest transactions for each holding click on a transaction to see Andrew Ashe's performance on stock
You May Also Like
Andrew Ashe insider profile FAQ
What is the percentage of profitable transactions made by Andrew Ashe?
The percentage of profitable transactions made by Andrew Ashe is 0%.
What is the average return per transaction made by Andrew Ashe?
The average return per transaction made by Andrew Ashe is -29.70%.
What stocks does Andrew Ashe hold?
Andrew Ashe holds: DYAX, AGTC, VERV stocks.
What was Andrew Ashe’s latest transaction?
Andrew Ashe latest transaction was an Uninformative Sell of ―.
What was Andrew Ashe's most profitable transaction?
Andrew Ashe’s most profitable transaction was an Informative Buy of VERV stock on May 15, 2024. The return on the trade was -7.80%.
What is Andrew Ashe's role in Dyax Corp?
Andrew Ashe's role in Dyax Corp is General Counsel & EVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.